Q1 2027 Cholamandalam Financial Holdings Ltd Earnings Call Transcript
Key Points
- Cholamandalam Financial Holdings Ltd (BOM:504973) reported a robust solvency ratio of 1.93 times, well above regulatory requirements, reflecting strong balance sheet strength.
- The company's investment portfolio remains robust at INR19,000 crores, with improved portfolio yield to 7.31% through active management, generating investment income of approximately INR380 crores in the quarter.
- Despite industry-wide fire segment degrowth of 28%, Cholamandalam Financial Holdings Ltd (BOM:504973) limited its degrowth to 15.5%, outperforming the industry due to better reinsurance capacities and a diversified commercial lines portfolio.
- The company is taking proactive corrective measures in motor and health portfolios, including targeted pricing interventions, enhanced NCB sourcing, and tighter underwriting controls, with management confident of improving motor OD loss ratios to sub-80% over time.
- Cholamandalam Financial Holdings Ltd (BOM:504973) has a strong hospital network of over 13,000, providing a solid backbone for future retail health growth, and is focusing on SME segments where pricing competition is less intense.
- The company completed the BaNCS rollout for motor issuance, enhancing operational efficiency, and is actively working on technology-driven claims management improvements.
- Cholamandalam Financial Holdings Ltd (BOM:504973) reported a combined ratio of 120.4% for Q1 FY27, reflecting elevated motor reserving, poor Motor OD experience, and a large fire loss, indicating significant underwriting pressure.
- The company's GDPI growth was only 2.6% year-over-year, below expectations, impacted by lower volumes in commercial and motor segments and a highly competitive market environment.
- Motor OD loss ratios have deteriorated to 80%+ levels, and management acknowledges that corrective measures will take several quarters to turn the tide, with no immediate respite expected.
- The health portfolio experienced degrowth due to pricing corrections and strategic exits from unprofitable group health accounts, with retail health growth lagging the industry significantly.
- The company has not yet made provisions for the Supreme Court judgment on housewife claims, and the potential financial impact remains uncertain, posing a future risk to profitability.
- Commercial lines, particularly fire, continue to face intense pricing competition and rate reductions, with management expecting that pricing discipline may only improve next year, not in the current fiscal.
Ladies and gentlemen, good day, and welcome to Cholamandalam Financial Holdings Limited Earnings Call for Q1 FY '27 Financial Results. (Operator Instructions). Please note that this conference is being recorded.
With that, I hand over the call to Mr. Rishi Jhunjhunwala from IIFL Capital. Thank you, and over to you.
Thank you, Swapnil. Good afternoon, everyone. Welcome to 1Q FY27 Earnings Call of Cholamandalam Financial Holdings Limited. From the management side, we have Mr. Sridharan Rangarajan, Non-Executive Director, Cholamandalam Financial Holdings; Mr. Shyam Shankar, Manager and Chief Financial Officer, Cholamandalam Financial Holdings; Mr. Rajive Kumaraswami, Managing Director, Cholamandalam MS General Insurance; and Mr. Santosh Pandey, Chief Financial Officer, Cholamandalam MS General Insurance.
I'll hand over the call to management for their opening remarks, post which we can open the floor for Q&A. Over to you, Mr. Rangarajan. Thank you.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
